InflaRx NV (IFRX)
1.05
-0.01
(-0.94%)
USD |
NASDAQ |
Dec 09, 16:00
1.05
0.00 (0.00%)
After-Hours: 20:00
InflaRx Market Cap: 71.13M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CDT Equity, Inc. | 2.884M |
| LENZ Therapeutics, Inc. | 825.43M |
| Liminatus Pharma, Inc. | 23.69M |
| Oruka Therapeutics, Inc. | 1.491B |
| Maze Therapeutics, Inc. | 1.963B |
Market Cap Related Metrics
| PS Ratio | 324.43 |
| PEG Ratio | -0.1731 |
| Price to Book Value | 1.334 |
| Price | 1.05 |
| Earnings Yield | -87.30% |
| PEGY Ratio | -0.1731 |